![Jennifer Augusti](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jennifer Augusti
Director of Finance/CFO at Xylocor Therapeutics, Inc.
Jennifer Augusti active positions
Companies | Position | Start | End |
---|---|---|---|
Xylocor Therapeutics, Inc.
![]() Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | Chief Operating Officer | - | - |
Director of Finance/CFO | - | - |
Career history of Jennifer Augusti
Statistics
International
United States | 2 |
Operational
Chief Operating Officer | 1 |
Director of Finance/CFO | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Xylocor Therapeutics, Inc.
![]() Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | Health Technology |
- Stock Market
- Insiders
- Jennifer Augusti
- Experience